<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:bir="http://www.alacra.com/bir" xmlns:ccbn="http://www.alacra.com/ccbn" xmlns:srp="http://www.alacra.com/srp" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>Trubion Pharmaceuticals, Inc. RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Trubion Pharmaceuticals, Inc.</description>
<link>http://www.alacrastore.com/company-snapshot/Trubion_Pharmaceuticals_Inc-3640067</link>
<lastBuildDate>Friday, January 09, 2009 1:50:10 AM</lastBuildDate>
<alacra:xlsid>3640067</alacra:xlsid>
<alacra:company>Trubion Pharmaceuticals, Inc.</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-29420824</link><guid isPermaLink="false">newstex/PRN-0005-29420824</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> SEATTLE, Nov. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN) announced today financial results for its third quarter and nine months ended Sept. ##, ####.Third Quarter and Nine Months...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07005000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010005</newstex:cat><pubDate>11/10/2008 5:22:58 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-29420824</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">TRUBION PHARMACEUTICALS INC</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">WYETH</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">Peter A Thompson</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">TRBN</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">WYE</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-29145344</link><guid isPermaLink="false">newstex/PRN-0005-29145344</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> SEATTLE, Nov. #, #### (PRNewswire-FirstCall delivered by Newstex) -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN) today announced that it plans to issue earnings results for the third quarter and nine months ended Sept. ##, ####, after...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010005</newstex:cat><pubDate>11/3/2008 5:23:15 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Trubion Pharmaceuticals Provides Announcement Dates for Third-Quarter and Nine Months Earnings Conference Call</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-29145344</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">TRUBION PHARMACEUTICALS INC</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">Trubion Pharmaceuticals Inc.</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">TRBN</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/bir/1318164</link><guid isPermaLink="false">bir/1318164</guid><bir:index_mode xmlns:bir="http://www.alacra.com/bir">norm</bir:index_mode><title>Trubion Pharmaceuticals Inc.</title><bir:company xmlns:bir="http://www.alacra.com/bir">Trubion Pharmaceuticals Inc.</bir:company><bir:cou xmlns:bir="http://www.alacra.com/bir">United States</bir:cou><bir:descr xmlns:bir="http://www.alacra.com/bir">Manufacturing: Pharmaceutical development for autoimmune diseases including rheumatoid arthritis.</bir:descr><bir:sic xmlns:bir="http://www.alacra.com/bir">2834</bir:sic><bir:ssic xmlns:bir="http://www.alacra.com/bir">8731</bir:ssic><bir:ssic xmlns:bir="http://www.alacra.com/bir">2836</bir:ssic><bir:naics xmlns:bir="http://www.alacra.com/bir">325412</bir:naics><bir:snaics xmlns:bir="http://www.alacra.com/bir">325414</bir:snaics><bir:snaics xmlns:bir="http://www.alacra.com/bir">541710</bir:snaics><bir:class xmlns:bir="http://www.alacra.com/bir">17</bir:class><bir:size xmlns:bir="http://www.alacra.com/bir">B</bir:size><bir:revenue xmlns:bir="http://www.alacra.com/bir">E</bir:revenue><bir:ticker xmlns:bir="http://www.alacra.com/bir">TRBN</bir:ticker><pubDate>10/29/2008 6:22:00 AM</pubDate><bir:docid xmlns:bir="http://www.alacra.com/bir">1318164</bir:docid><category>Company Profiles &amp; Financials</category><alacra:ip>Gale Company Profiles</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1790927</link><guid isPermaLink="false">ccbn/T1790927</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good afternoon, ladies and gentlemen, and welcome to the Trubion fourth quarter and year end #### earnings conference call. Today's call is being recorded. At this time, I would like to turn the call over to Trubion Senior Director of Corporate Communications, Mr. Jim DeNike. Please go ahead, sir. ...

</description><pubDate>3/13/2008 8:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">TRUBION PHARMA INC</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q4 2007 TRUBION PHARMA INC Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">TRBN</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">2:00pm PT</ccbn:time><title>Q4 2007 TRUBION PHARMA INC Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1790927</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/srp/78976869</link><guid isPermaLink="false">srp/78976869</guid><srp:index_mode xmlns:srp="http://www.alacra.com/srp">norm</srp:index_mode><description>...Address:#### #th Avenue, Suite ####, Seattle, Washington ##### Incorporated:DelawareWeb Site: www.trubion.comSIC Classification: Pharmaceutical Preparations (####) Business Description: Trubion Pharmaceuticals, Inc. is biopharmaceutical company which creates product candidates to treat autoimmune disease and cancer. IPO Date: ##-##-####...

</description><srp:company xmlns:srp="http://www.alacra.com/srp">78976869</srp:company><title>Trubion Pharmaceuticals, Inc.</title><srp:cusip xmlns:srp="http://www.alacra.com/srp">89778N102</srp:cusip><srp:ticker xmlns:srp="http://www.alacra.com/srp">TRBN</srp:ticker><pubDate>10/23/2006 7:17:00 AM</pubDate><srp:docid xmlns:srp="http://www.alacra.com/srp">78976869</srp:docid><category>Credit &amp; Investment Research</category><alacra:ip>SharkRepellent.net</alacra:ip></item></channel></rss>